Boehringer Ingelheim
Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Around 52,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals.


Audits
EA:
1.5
MO:
4
RP:
1
Total:
6.5
Clinical audit: An update on organ protection in T2D: focus on cardiorenal disease

Modules
EA:
1.5
MO:
0
RP:
0
Total:
1.5
On-demand webinar: Chronic kidney disease - what GPs can do to prevent progression and premature death

Audits
EA:
1.5
MO:
4
RP:
1
Total:
6.5
Clinical audit: Chronic kidney disease (CKD) - preventing progression and premature death in general practice

Audits
EA:
1
MO:
4
RP:
1
Total:
6
Clinical audit: Management of heart failure with reduced ejection fraction